Articles

Federally qualified health centers (FQHCs) and other federal grantees participating in the federal 340B drug discount statute face potentially devastating, practical effects on their ability to serve vulnerable patient populations from a [...]

Most government agencies charged with enforcement responsibilities seek to publicize their enforcement efforts and provide transparency into their standards. Doing so simultaneously increases the reach of those enforcement efforts while also promoting [...]

November 6, 2024, marked one year since the Office of Inspector General (OIG) released its General Compliance Program Guidance (GCPG). Issued 15 years since OIG’s last updates to the previous compliance program [...]

In a one-of-a-kind decision that flies in the face of decades of precedent, a Florida federal district court recently held that the False Claims Act’s ("FCA") qui tam provisions are unconstitutional as [...]

In a landmark decision, the Supreme Court has permitted the Department of Health and Human Services (HHS) to withhold millions in Title X funding from Oklahoma over the state’s refusal to comply [...]

The U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) recently released its third ransomware-related settlement agreement in less than a year. Below we summarize each of the [...]

A Recent Settlement, and DOJ Intervention in an Ongoing Case, Highlight Cybersecurity as a False Claims Act Enforcement Priority The U.S. Department of Justice’s (DOJ) increasingly-active Civil Cyber Fraud Initiative has made [...]

Pandemic-related fraud and false claims remain a high priority for the Department of Justice (DOJ). Despite low recoveries in federal fiscal year 2023 in the area of COVID-19 related fraud, DOJ is [...]

A rarely-used – but important – False Claims Act (FCA) provision recently turned the typical attorneys’ fees repayment award on its head, when a Mississippi federal judge used the statutory authority to [...]

Florida-based non-profit cancer treatment and research center H. Lee Moffitt (Moffitt) agreed to pay $19,564,743 to resolve its self-disclosure related to improper claims for patient care items and services provided during research [...]